{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:11:20Z","timestamp":1772136680905,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Photochem Photobiol Sci"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1039\/c2pp25203a","type":"journal-article","created":{"date-parts":[[2012,8,20]],"date-time":"2012-08-20T10:30:40Z","timestamp":1345458640000},"page":"174-181","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Extracorporeal photochemotherapy as systemic monotherapy of severe, refractory atopic dermatitis: results from a prospective trial"],"prefix":"10.1007","volume":"12","author":[{"given":"Peter","family":"Wolf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Georgas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nordwig S.","family":"Tomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph M.","family":"Schempp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,1]]},"reference":[{"key":"1201020_CR1","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1468-3083.2009.03415.x","volume":"24","author":"U Darsow","year":"2010","unstructured":"U. Darsow, A. Wollenberg, D. Simon, A. Taieb, T. Werfel, A. Oranje, C. Gelmetti, A. Svensson, M. Deleuran, A. M. Calza, F. Giusti, J. Lubbe, S. Seidenari, and J. Ring, ETFAD\/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis, J. Eur. Acad. Dermatol. Venereol., 2010, 24, 317\u2013328.","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"1201020_CR2","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1346-8138.2009.00706.x","volume":"36","author":"H Saeki","year":"2009","unstructured":"H. Saeki, M. Furue, F. Furukawa, M. Hide, M. Ohtsuki, I. Katayama, R. Sasaki, H. Suto, and K. Takehara, Committee for guidelines for the management of atopic dermatitis of Japanese dermatological association. Guidelines for management of atopic dermatitis, J. Dermatol., 2009, 36, 563\u2013577.","journal-title":"J. Dermatol."},{"issue":"Suppl1","key":"1201020_CR3","first-page":"S1","volume":"7","author":"T Werfel","year":"2009","unstructured":"T. Werfel, W. Aberer, M. Augustin, T. Biedermann, R. Folster-Holst, F. Friedrichs, U. Gieler, A. Heratizadeh, A. Kapp, B. Przybilla, E. Rietschel, M. Schlaeger, P. Schmid-Grendelmeier, H. Sitters, D. Staab, R. Szczepanski, D. Vieluf, I. Voigtmann, and M. Worm, Atopic dermatitis: S2 guidelines, J. Dtsch. Dermatol. Ges., 2009, 7 Suppl 1, S1\u201346.","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"1201020_CR4","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.jaci.2004.01.772","volume":"113","author":"L S Ou","year":"2004","unstructured":"L. S. Ou, E. Goleva, C. Hall, and D. Y. Leung, T regulatory cells in atopic dermatitis and subversion of their activity by superantigens, J. Allergy Clin. Immunol., 2004, 113, 756\u2013763.","journal-title":"J. Allergy Clin. Immunol."},{"key":"1201020_CR5","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/S0140-6736(04)15592-X","volume":"363","author":"E M Ling","year":"2004","unstructured":"E. M. Ling, T. Smith, X. D. Nguyen, C. Pridgeon, M. Dallman, J. Arbery, V. A. Carr, and D. S. Robinson, Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease, Lancet, 2004, 363, 608\u2013615.","journal-title":"Lancet"},{"key":"1201020_CR6","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1038\/jid.2008.283","volume":"128","author":"A Di Cesare","year":"2008","unstructured":"A. Di Cesare, P. Di Meglio, and F. O. Nestle, A role for Th17 cells in the immunopathogenesis of atopic dermatitis?, J. Invest. Dermatol., 2008, 128, 2569\u20132571.","journal-title":"J. Invest. Dermatol."},{"key":"1201020_CR7","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.jaci.2009.04.003","volume":"123","author":"J Louten","year":"2009","unstructured":"J. Louten, K. Boniface, R. de Waal Malefyt, Development and function of TH17 cells in health and disease, J. Allergy Clin. Immunol., 2009, 123, 1004\u20131011.","journal-title":"J. Allergy Clin. Immunol."},{"key":"1201020_CR8","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1136\/bmj.298.6685.1426","volume":"298","author":"G B Colver","year":"1989","unstructured":"G. B. Colver, J. A. Symons, and G. W. Duff, Soluble interleukin 2 receptor in atopic eczema, Br. Med. J., 1989, 298, 1426\u20131428.","journal-title":"Br. Med. J."},{"key":"1201020_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1046\/j.1365-2133.1999.02609.x","volume":"140","author":"M Furue","year":"1999","unstructured":"M. Furue, T. Koga, and N. Yamashita, Soluble E-selectin and eosinophil cationic protein are distinct serum markers that differentially represent clinical features of atopic dermatitis, Br. J. Dermatol., 1999, 140, 67\u201372.","journal-title":"Br. J. Dermatol."},{"key":"1201020_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1001\/archderm.139.2.223","volume":"139","author":"F J Legat","year":"2003","unstructured":"F. J. Legat, A. Hofer, E. Brabek, F. Quehenberger, H. Kerl, and P. Wolf, Narrowband UV-B vs. medium-dose UV-A1 phototherapy in chronic atopic dermatitis, Arch. Dermatol., 2003, 139, 223\u2013224.","journal-title":"Arch. Dermatol."},{"key":"1201020_CR11","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/j.1365-2133.2009.09514.x","volume":"162","author":"S Tzaneva","year":"2010","unstructured":"S. Tzaneva, H. Kittler, G. Holzer, D. Reljic, M. Weber, H. Honigsmann, and A. Tanew, 5-Methoxypsoralen plus ultraviolet (UV) A is superior to medium-dose UVA1 in the treatment of severe atopic dermatitis: a randomized crossover trial, Br. J. Dermatol., 2010, 162, 655\u2013660.","journal-title":"Br. J. Dermatol."},{"key":"1201020_CR12","first-page":"121797","volume":"2012","author":"S A Grundmann","year":"2012","unstructured":"S. A. Grundmann, and S. Beissert, Modern aspects of phototherapy for atopic dermatitis, J. Allergy (Cairo), 2012, 2012, 121797.","journal-title":"J. Allergy (Cairo)"},{"key":"1201020_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00403-008-0923-5","volume":"301","author":"T Gambichler","year":"2009","unstructured":"T. Gambichler, Management of atopic dermatitis using photo(chemo)therapy, Arch. Dermatol. Res., 2009, 301, 197\u2013203.","journal-title":"Arch. Dermatol. Res."},{"key":"1201020_CR14","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.jaad.2004.11.022","volume":"52","author":"A Jacobi","year":"2005","unstructured":"A. Jacobi, C. Antoni, B. Manger, G. Schuler, and M. Hertl, Infliximab in the treatment of moderate to severe atopic dermatitis, J. Am. Acad. Dermatol., 2005, 52, 522\u2013526.","journal-title":"J. Am. Acad. Dermatol."},{"key":"1201020_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1365-4632.2011.05195.x","volume":"51","author":"R Puya","year":"2012","unstructured":"R. Puya, M. Alvarez-Lopez, A. Velez, E. Casas Asuncion, and J. C. Moreno, Treatment of severe refractory adult atopic dermatitis with ustekinumab, Int. J. Dermatol., 2012, 51, 115\u2013116.","journal-title":"Int. J. Dermatol."},{"key":"1201020_CR16","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1398-9995.2005.00791.x","volume":"60","author":"J M Oldhoff","year":"2005","unstructured":"J. M. Oldhoff, U. Darsow, T. Werfel, K. Katzer, A. Wulf, J. Laifaoui, D. J. Hijnen, S. Plotz, E. F. Knol, A. Kapp, C. A. Bruijnzeel-Koomen, J. Ring, M. S. de Bruin-Weller, Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis, Allergy, 2005, 60, 693\u2013696.","journal-title":"Allergy"},{"key":"1201020_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/BF00370718","volume":"287","author":"B Prinz","year":"1994","unstructured":"B. Prinz, F. Nachbar, and G. Plewig, Treatment of severe atopic dermatitis with extracorporeal photopheresis, Arch. Dermatol. Res., 1994, 287, 48\u201352.","journal-title":"Arch. Dermatol. Res."},{"key":"1201020_CR18","doi-asserted-by":"publisher","first-page":"635","DOI":"10.2340\/00015555-0952","volume":"90","author":"K P Hjuler","year":"2010","unstructured":"K. P. Hjuler, C. Vestergaard, and M. Deleuran, A retrospective study of six cases of severe recalcitrant atopic dermatitis treated with long-term extracorporeal photopheresis, Acta Derm.-Venereol., 2010, 90, 635\u2013636.","journal-title":"Acta Derm.-Venereol."},{"key":"1201020_CR19","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/S0190-9622(99)70167-2","volume":"40","author":"G Mohla","year":"1999","unstructured":"G. Mohla, N. Horvath, and S. Stevens, Quality of life improvement in a patient with severe atopic dermatitis treated with photopheresis, J. Am. Acad. Dermatol., 1999, 40, 780\u2013782.","journal-title":"J. Am. Acad. Dermatol."},{"key":"1201020_CR20","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0190-9622(99)70440-8","volume":"40","author":"B Prinz","year":"1999","unstructured":"B. Prinz, S. Michelsen, C. Pfeiffer, and G. Plewig, Long-term application of extracorporeal photochemotherapy in severe atopic dermatitis, J. Am. Acad. Dermatol., 1999, 40, 577\u2013582.","journal-title":"J. Am. Acad. Dermatol."},{"key":"1201020_CR21","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1111\/j.1346-8138.2004.tb00638.x","volume":"31","author":"M Radenhausen","year":"2004","unstructured":"M. Radenhausen, S. Michelsen, G. Plewig, F. G. Bechara, P. Altmeyer, and K. Hoffmann, Bicentre experience in the treatment of severe generalised atopic dermatitis with extracorporeal photochemotherapy, J. Dermatol., 2004, 31, 961\u2013970.","journal-title":"J. Dermatol."},{"key":"1201020_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/00015550310002710","volume":"83","author":"M Radenhausen","year":"2003","unstructured":"M. Radenhausen, G. von Kobyletzki, S. Hoxtermann, P. Altmeyer, and K. Hoffmann, Activation markers in severe atopic dermatitis following extracorporeal photochemotherapy, Acta Derm.-Venereol., 2003, 83, 49\u201350.","journal-title":"Acta Derm.-Venereol."},{"key":"1201020_CR23","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S0190-9622(98)70122-7","volume":"38","author":"H I Richter","year":"1998","unstructured":"H. I. Richter, C. Billmann-Eberwein, M. Grewe, H. Stege, M. Berneburg, T. Ruzicka, and J. Krutmann, Successful monotherapy of severe and intractable atopic dermatitis by photopheresis, J. Am. Acad. Dermatol., 1998, 38, 585\u2013588.","journal-title":"J. Am. Acad. Dermatol."},{"key":"1201020_CR24","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1159\/000104265","volume":"215","author":"M Sand","year":"2007","unstructured":"M. Sand, F. G. Bechara, D. Sand, M. Radenhausen, N. S. Tomi, P. Altmeyer, and K. Hoffmann, Extracorporeal photopheresis as a treatment for patients with severe, refractory atopic dermatitis, Dermatology, 2007, 215, 134\u2013138.","journal-title":"Dermatology"},{"key":"1201020_CR25","volume-title":"J. Eur. Acad. Dermatol. Venereol.","author":"P Rubegni","year":"2012","unstructured":"P. Rubegni, S. Poggiali, G. Cevenini, G. D\u2018Ascenzo, A. Perrone, M. L. Flori, P. Barbini, and M. Fimiani, Long term follow-up results on severe recalcitrant atopic dermatitis treated with extracorporeal photochemotherapy, J. Eur. Acad. Dermatol. Venereol., 2012. 10.1111\/j.1468-3083.2012.04552.x."},{"key":"1201020_CR26","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1034\/j.1600-0781.2000.160505.x","volume":"16","author":"R R Muellegger","year":"2000","unstructured":"R. R. Muellegger, A. Hofer, W. Salmhofer, H. P. Soyer, H. Kerl, and P. Wolf, Extended extracorporeal photochemotherapy with extracorporeal administration of 8-methoxypsoralen in systemic sclerosis. An Austrian single-center study, Photodermatol., Photoimmunol. Photomed., 2000, 16, 216\u2013223.","journal-title":"Photodermatol., Photoimmunol. Photomed."},{"key":"1201020_CR27","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/j.1365-2133.2005.07050.x","volume":"154","author":"E A Holm","year":"2006","unstructured":"E. A. Holm, H. C. Wulf, H. Stegmann, and G. B. Jemec, Life quality assessment among patients with atopic eczema, Br. J. Dermatol., 2006, 154, 719\u2013725.","journal-title":"Br. J. Dermatol."},{"key":"1201020_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000078581","volume":"209","author":"M Augustin","year":"2004","unstructured":"M. Augustin, K. Wenninger, U. Amon, M. J. Schroth, W. Kuster, M. Chren, J. Kupfer, and U. Gieler, German adaptation of the Skindex-29 questionnaire on quality of life in dermatology: validation and clinical results, Dermatology, 2004, 209, 14\u201320.","journal-title":"Dermatology"},{"key":"1201020_CR29","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/1523-1747.ep12365600","volume":"107","author":"M M Chren","year":"1996","unstructured":"M. M. Chren, R. J. Lasek, L. M. Quinn, E. N. Mostow, and S. J. Zyzanski, Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness, J. Invest. Dermatol., 1996, 107, 707\u2013713.","journal-title":"J. Invest. Dermatol."},{"key":"1201020_CR30","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s00038-005-4090-6","volume":"50","author":"M Morfeld","year":"2005","unstructured":"M. Morfeld, M. Bullinger, J. Nantke, and E. Brahler, The version 2.0 of the SF-36 health survey: results of a population-representative study, Soz.- Praeventivmed., 2005, 50, 292\u2013300.","journal-title":"Soz.- Praeventivmed."},{"key":"1201020_CR31","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1055\/s-2003-41645","volume":"42","author":"M Bullinger","year":"2003","unstructured":"M. Bullinger, M. Morfeld, T. Kohlmann, J. Nantke, H. van den Bussche, B. Dodt, S. Dunkelberg, I. Kirchberger, A. Kruger-Bodecker, A. Lachmann, K. Lang, C. Mathis, O. Mittag, A. Peters, H. H. Raspe, and H. Schulz, SF-36 Health survey in rehabilitation research. Findings from the North German network for rehabilitation research, NVRF, within the rehabilitation research funding program, Rehabilitation (Stuttg), 2003, 42, 218\u2013225.","journal-title":"Rehabilitation (Stuttg)"},{"key":"1201020_CR32","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/0277-9536(95)00115-N","volume":"41","author":"M Bullinger","year":"1995","unstructured":"M. Bullinger, German translation and psychometric testing of the SF-36 health survey: preliminary results from the IQOLA project. International quality of life assessment, Soc. Sci. Med., 1995, 41, 1359\u20131366.","journal-title":"Soc. Sci. Med."},{"key":"1201020_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11136-010-9727-0","volume":"20","author":"R Sanchez","year":"2011","unstructured":"R. Sanchez, M. Ballesteros, and B. J. Arnold, Validation of the FACT-G scale for evaluating quality of life in cancer patients in Colombia, Qual. Life Res., 2011, 20, 19\u201329.","journal-title":"Qual. Life Res."},{"key":"1201020_CR34","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.2741\/3566","volume":"14","author":"T Dani","year":"2009","unstructured":"T. Dani, and R. Knobler, Extracorporeal photoimmunotherapy-photopheresis, Front. Biosci., 2009, 14, 4769\u20134777.","journal-title":"Front. Biosci."},{"key":"1201020_CR35","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jaad.2009.02.039","volume":"61","author":"R Knobler","year":"2009","unstructured":"R. Knobler, M. L. Barr, D. R. Couriel, J. L. Ferrara, L. E. French, P. Jaksch, W. Reinisch, A. H. Rook, T. Schwarz, and H. Greinix, Extracorporeal photopheresis: past, present, and future, J. Am. Acad. Dermatol., 2009, 61, 652\u2013665.","journal-title":"J. Am. Acad. Dermatol."},{"key":"1201020_CR36","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000246654","volume":"190","author":"R Knobler","year":"1995","unstructured":"R. Knobler, Photopheresis and the red man syndrome, Dermatology, 1995, 190, 97\u201398.","journal-title":"Dermatology"},{"key":"1201020_CR37","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1159\/000246662","volume":"190","author":"H Zachariae","year":"1995","unstructured":"H. Zachariae, P. Bjerring, U. Brodthagen, and H. Sogaard, Photopheresis in the red man or pre-Sezary syndrome, Dermatology, 1995, 190, 132\u2013135.","journal-title":"Dermatology"},{"key":"1201020_CR38","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1001\/archderm.135.4.475","volume":"135","author":"A Hofer","year":"1999","unstructured":"A. Hofer, R. Mullegger, H. Kerl, and P. Wolf, Extracorporeal photochemotherapy for the treatment of erythrodermic pityriasis rubra pilaris, Arch. Dermatol., 1999, 135, 475\u2013476.","journal-title":"Arch. Dermatol."},{"key":"1201020_CR39","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0190-9622(96)90651-9","volume":"35","author":"P Wolf","year":"1996","unstructured":"P. Wolf, R. Mullegger, L. Cerroni, R. Aigner, G. Fueger, G. Hofler, J. Derbaschnig, and H. Kerl, Photoaccentuated erythroderma associated with CD4+ T lymphocytopenia: successful treatment with 5-methoxypsoralen and UVA, interferon alfa-2b, and extracorporeal photopheresis, J. Am. Acad. Dermatol., 1996, 35, 291\u2013294.","journal-title":"J. Am. Acad. Dermatol."},{"key":"1201020_CR40","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.2741\/3530","volume":"14","author":"S A Grundmann","year":"2009","unstructured":"S. A. Grundmann, and S. Beissert, Regulation of cellular immunity by photo(chemo)therapy, Front. Biosci., 2009, 14, 4326\u20134336.","journal-title":"Front. Biosci."},{"key":"1201020_CR41","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1600-0625.2012.01491.x","volume":"21","author":"U Just","year":"2012","unstructured":"U. Just, E. Dimou, R. Knobler, G. Klosner, E. Ivancic-Brandenberger, H. Greinix, A. Becherer, and F. Trautinger, Leucocyte scintigraphy with (111) in-oxine for assessment of cell trafficking after extracorporeal photopheresis, Exp. Dermatol., 2012, 21, 443\u2013447.","journal-title":"Exp. Dermatol."},{"key":"1201020_CR42","doi-asserted-by":"publisher","first-page":"5956","DOI":"10.4049\/jimmunol.181.9.5956","volume":"181","author":"A Maeda","year":"2008","unstructured":"A. Maeda, A. Schwarz, A. Bullinger, A. Morita, D. Peritt, and T. Schwarz, Experimental extracorporeal photopheresis inhibits the sensitization and effector phases of contact hypersensitivity via two mechanisms: generation of IL-10 and induction of regulatory T cells, J. Immunol., 2008, 181, 5956\u20135962.","journal-title":"J. Immunol."},{"key":"1201020_CR43","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1177\/039463200902200212","volume":"22","author":"P Quaglino","year":"2009","unstructured":"P. Quaglino, A. Comessatti, R. Ponti, A. Peroni, F. Mola, M. T. Fierro, P. Savoia, M. Novelli, and M. G. Bernengo, Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients, Int. J. Immunopathol. Pharmacol., 2009, 22, 353\u2013362.","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"1201020_CR44","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.ajpath.2010.10.008","volume":"178","author":"T P Singh","year":"2011","unstructured":"T. P. Singh, B. Huettner, H. Koefeler, G. Mayer, I. Bambach, K. Wallbrecht, M. P. Schon, and P. Wolf, Platelet-activating factor blockade inhibits the T-helper type 17 cell pathway and suppresses psoriasis-like skin disease in K5.hTGF-beta1 transgenic mice, Am. J. Pathol., 2011, 178, 699\u2013708.","journal-title":"Am. J. Pathol."},{"key":"1201020_CR45","doi-asserted-by":"publisher","first-page":"7257","DOI":"10.4049\/jimmunol.0903719","volume":"184","author":"T P Singh","year":"2010","unstructured":"T. P. Singh, M. P. Schon, K. Wallbrecht, K. Michaelis, B. Rinner, G. Mayer, U. Schmidbauer, H. Strohmaier, X. J. Wang, and P. Wolf, 8-Methoxypsoralen plus ultraviolet A therapy acts via inhibition of the IL-23\/Th17 axis and induction of Foxp3+ regulatory T cells involving CTLA4 signaling in a psoriasis-like skin disorder, J. Immunol., 2010, 184, 7257\u20137267.","journal-title":"J. Immunol."},{"key":"1201020_CR46","doi-asserted-by":"publisher","first-page":"228","DOI":"10.7150\/ijbs.8.228","volume":"8","author":"G Han","year":"2012","unstructured":"G. Han, F. Li, T. P. Singh, P. Wolf, and X. J. Wang, The pro-inflammatory role of TGFbeta1: a paradox?, Int. J. Biol. Sci., 2012, 8, 228\u2013235.","journal-title":"Int. J. Biol. Sci."},{"key":"1201020_CR47","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1056\/NEJMoa1104200","volume":"365","author":"S Eyerich","year":"2011","unstructured":"S. Eyerich, A. T. Onken, S. Weidinger, A. Franke, F. Nasorri, D. Pennino, M. Grosber, F. Pfab, C. B. Schmidt-Weber, M. Mempel, R. Hein, J. Ring, A. Cavani, and K. Eyerich, Mutual antagonism of T cells causing psoriasis and atopic eczema, N. Engl. J. Med., 2011, 365, 231\u2013238.","journal-title":"N. Engl. J. Med."},{"key":"1201020_CR48","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1600-0625.2011.01437.x","volume":"21","author":"T P Singh","year":"2012","unstructured":"T. P. Singh, M. P. Schon, K. Wallbrecht, and P. Wolf, 8-Methoxypsoralen plus UVA treatment increases the proportion of CLA+ CD25+ CD4+ T cells in lymph nodes of K5.hTGFbeta1 transgenic mice, Exp. Dermatol., 2012, 21, 228\u2013230.","journal-title":"Exp. Dermatol."},{"key":"1201020_CR49","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1038\/jid.2010.325","volume":"131","author":"T P Singh","year":"2011","unstructured":"T. P. Singh, M. P. Sch\u00f6n, A. Gruber-Wackernagel, K. Wallbrecht, X. J. Wang, and P. Wolf, Role of IL-9 in Th17-associated inflammation, hyperproliferation, and angiogenesis in psoriasis, J. Invest. Dermatol., 2011, 131, S6. (abstract).","journal-title":"J. Invest. Dermatol."},{"key":"1201020_CR50","doi-asserted-by":"publisher","first-page":"e33271","DOI":"10.1371\/journal.pone.0033271","volume":"7","author":"N Sismanopoulos","year":"2012","unstructured":"N. Sismanopoulos, D. A. Delivanis, K. D. Alysandratos, A. Angelidou, M. Vasiadi, A. Therianou, and T. C. Theoharides, IL-9 induces VEGF secretion from human mast cells and IL-9\/IL-9 receptor genes are overexpressed in atopic dermatitis, PLoS One, 2012, 7, e33271.","journal-title":"PLoS One"},{"key":"1201020_CR51","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2353\/ajpath.2006.060079","volume":"169","author":"P Wolf","year":"2006","unstructured":"P. Wolf, D. X. Nghiem, J. P. Walterscheid, S. Byrne, Y. Matsumura, C. Bucana, H. N. Ananthaswamy, and S. E. Ullrich, Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis, Am. J. Pathol., 2006, 169, 795\u2013805.","journal-title":"Am. J. Pathol."}],"container-title":["Photochemical & Photobiological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1039\/c2pp25203a.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1039\/c2pp25203a\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/pubs.rsc.org\/en\/content\/articlepdf\/2013\/PP\/C2PP25203A","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1039\/c2pp25203a.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T09:53:25Z","timestamp":1667382805000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1039\/c2pp25203a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["1201020"],"URL":"https:\/\/doi.org\/10.1039\/c2pp25203a","relation":{},"ISSN":["1474-905X","1474-9092"],"issn-type":[{"value":"1474-905X","type":"print"},{"value":"1474-9092","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"20 June 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}